CLSI M39 A3 : 3ED 2009

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Information System Design
6 Data Analysis
7 Data Presentation
8 Use of Cumulative Antimicrobial Susceptibility Reports
9 Limitations of Data, Data Analysis and Data Presentation
10 Statistical Considerations
References
Additional References
Appendix A - Suggestions for Verification of Antimicrobial
             Susceptibility Test Results and Confirmation
             of Organism Identification
Appendix B - Rationale Behind the 'First Isolate per Patient'
             Analysis Recommendation
Appendix C - Example of Supplemental Analyses - Stratifying
             Cumulative Antibiogram Data by Various Parameters
Appendix E1 - Cumulative Antimicrobial Susceptibility Report
              Example - Antimicrobial Agents Listed
              Alphabetically (Hypothetical Data
Appendix E2 - Cumulative Antimicrobial Susceptibility Report
              Example - Antimicrobial Agents Listed by Class
              (Hypothetical Data)
Appendix F - Example of Graph to Illustrated Trend in
             Susceptibility Over Five Years
Appendix G - Steps for Presenting Local Cumulative Antibiogram
             Report to Health Care Professionals
Appendix H - Statistical Methods for Examining Percent
             Susceptible
Appendix I - Glossary I (Part 1) - Beta-lactams: Class and
             Subclass Designation and Generic Name
Glossary I (Part 2) - Non-Beta-lactams: Class and Subclass
                      Designation and Generic Name
Glossary II - Abbreviations/Routes of Administration/Drug
              Class for Antimicrobial Agents
Summary of Delegate Comments and Subcommittee Responses
The Quality Management System Approach
Related CLSI Reference Materials

Specifies methods for recording and analysis of antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant microorganisms.